YAP1 and cancer: Given the crucial role of the Hippo pathway, particularly its core effectors YAP/TAZ, in immune evasion, their aberrant activation is closely associated with tumor initiation, progression, and immune escape, highlighting their growing importance as critical therapeutic targets in cancer.